SCHEMBL17634428

SCHEMBL17634428

C=C1CC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]2(C)[C@]1(O)C#CSC(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 9/20 0.54
▸ LMNA P02545 4/20 0.54
▸ NR3C1 P04150 5/20 0.52
▸ NR3C2 P08235 5/20 0.52
▸ SMN1; SMN2 Q16637 5/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ SERPINA6 P08185 3/20 0.52
▸ CYP3A4 P08684 3/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ PGR P06401 2/20 0.52
▸ SHBG P04278 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ NFKB1 P19838 2/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ AR P10275 1/20 0.49
▸ CHRM1 P11229 1/20 0.49
▸ HSD11B1 P28845 2/20 0.49
▸ HSD11B2 P80365 2/20 0.49
▸ BLM P54132 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16389277 1.00 HIF1A (0.54) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL16387366 0.86 HIF1A (0.54) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL16387356 0.86 HIF1A (0.54) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL16387364 0.85 HIF1A (0.57) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL16387355 0.85 HIF1A (0.57) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL17591544 0.85 HIF1A (0.57) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL16387349 0.85 HIF1A (0.61) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL15079260 0.85 HIF1A (0.61) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL16387365 0.80 HIF1A (0.51) HIF1ALMNANR3C1NR3C2SMN1; SMN2
SCHEMBL16387353 0.80 HIF1A (0.51) HIF1ALMNANR3C1NR3C2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296780-B2 Process for alkynylating 16-substituted-17-keto steroids CRYSTAL PHARMA, S.A.U. (ES) 2016-03-29 — — US disclosed
Send feedback